ATOS (Atossa Therapeutics) Interest Expense (Positive)


ATOS Atossa Therapeutics Inc ATOS
26 GF Score
Price $2.13
! 2 Warning Signs
View Full Analysis

What is Atossa Therapeutics Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.

ATOS
26GF Score
Atossa Therapeutics Inc ATOS
Interest Expense (Positive) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atossa Therapeutics Business Description

Other Exchanges ATOS:MexicoYAG:Germany
Address 1448 NW Market Street, Suite 500, Seattle, WA, USA, 98107
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
26GF Score

Get the complete analysis for ATOS

Interest Expense (Positive) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.13
Price